BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16987498)

  • 1. EDEM1 regulates ER-associated degradation by accelerating de-mannosylation of folding-defective polypeptides and by inhibiting their covalent aggregation.
    Olivari S; Cali T; Salo KE; Paganetti P; Ruddock LW; Molinari M
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1278-84. PubMed ID: 16987498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EDEM1 accelerates the trimming of alpha1,2-linked mannose on the C branch of N-glycans.
    Hosokawa N; Tremblay LO; Sleno B; Kamiya Y; Wada I; Nagata K; Kato K; Herscovics A
    Glycobiology; 2010 May; 20(5):567-75. PubMed ID: 20065073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-glycan processing in ER quality control.
    Ruddock LW; Molinari M
    J Cell Sci; 2006 Nov; 119(Pt 21):4373-80. PubMed ID: 17074831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EDEM accelerates ERAD by preventing aberrant dimer formation of misfolded alpha1-antitrypsin.
    Hosokawa N; Wada I; Natsuka Y; Nagata K
    Genes Cells; 2006 May; 11(5):465-76. PubMed ID: 16629899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of ERAD of misfolded null Hong Kong alpha1-antitrypsin by Golgi alpha1,2-mannosidases.
    Hosokawa N; You Z; Tremblay LO; Nagata K; Herscovics A
    Biochem Biophys Res Commun; 2007 Oct; 362(3):626-32. PubMed ID: 17727818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle.
    Molinari M; Calanca V; Galli C; Lucca P; Paganetti P
    Science; 2003 Feb; 299(5611):1397-400. PubMed ID: 12610306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin.
    Oda Y; Hosokawa N; Wada I; Nagata K
    Science; 2003 Feb; 299(5611):1394-7. PubMed ID: 12610305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinase.
    Svedine S; Wang T; Halaban R; Hebert DN
    J Cell Sci; 2004 Jun; 117(Pt 14):2937-49. PubMed ID: 15161941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin.
    Farinha CM; Amaral MD
    Mol Cell Biol; 2005 Jun; 25(12):5242-52. PubMed ID: 15923638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EDEM1 reveals a quality control vesicular transport pathway out of the endoplasmic reticulum not involving the COPII exit sites.
    Zuber C; Cormier JH; Guhl B; Santimaria R; Hebert DN; Roth J
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4407-12. PubMed ID: 17360537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannose trimming is required for delivery of a glycoprotein from EDEM1 to XTP3-B and to late endoplasmic reticulum-associated degradation steps.
    Groisman B; Shenkman M; Ron E; Lederkremer GZ
    J Biol Chem; 2011 Jan; 286(2):1292-300. PubMed ID: 21062743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EDEM1 recognition and delivery of misfolded proteins to the SEL1L-containing ERAD complex.
    Cormier JH; Tamura T; Sunryd JC; Hebert DN
    Mol Cell; 2009 Jun; 34(5):627-33. PubMed ID: 19524542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation.
    Sokołowska I; Wälchli S; Węgrzyn G; Sandvig K; Słomińska-Wojewódzka M
    Biochem J; 2011 Jun; 436(2):371-85. PubMed ID: 21388347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein folding, quality control and ER-associated degradation.
    Lederkremer GZ
    Curr Opin Struct Biol; 2009 Oct; 19(5):515-23. PubMed ID: 19616933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of an ERAD pathway mediated by the ER-resident protein disulfide reductase ERdj5.
    Hagiwara M; Maegawa K; Suzuki M; Ushioda R; Araki K; Matsumoto Y; Hoseki J; Nagata K; Inaba K
    Mol Cell; 2011 Feb; 41(4):432-44. PubMed ID: 21329881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EDEM1's mannosidase-like domain binds ERAD client proteins in a redox-sensitive manner and possesses catalytic activity.
    Lamriben L; Oster ME; Tamura T; Tian W; Yang Z; Clausen H; Hebert DN
    J Biol Chem; 2018 Sep; 293(36):13932-13945. PubMed ID: 30021839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.
    Chiritoiu M; Chiritoiu GN; Munteanu CVA; Pastrama F; Ivessa NE; Petrescu SM
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of N-glycan-dependent endoplasmic reticulum quality control factors for glycoprotein folding and degradation.
    Banerjee S; Vishwanath P; Cui J; Kelleher DJ; Gilmore R; Robbins PW; Samuelson J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11676-81. PubMed ID: 17606910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimming of glucosylated N-glycans by human ER α1,2-mannosidase I.
    Aikawa J; Takeda Y; Matsuo I; Ito Y
    J Biochem; 2014 Jun; 155(6):375-84. PubMed ID: 24519966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of N-linked glycans during endoplasmic-reticulum-associated degradation of a short-lived variant of ribophorin I.
    Kitzmüller C; Caprini A; Moore SE; Frénoy JP; Schwaiger E; Kellermann O; Ivessa NE; Ermonval M
    Biochem J; 2003 Dec; 376(Pt 3):687-96. PubMed ID: 12952521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.